Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 21 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CTD HOLDINGS INC | 15,806,269 | reported | 28 Sept 2020 | tx 16−1,213,293 |
| Vaxart, Inc. | 8,400,000 | reported | 27 May 2020 | tx 12+564,000−2,850,000 |
| ALIMERA SCIENCES INC | 6,936,000 | reported | 06 Feb 2018 | tx 9+20,000 |
| Del Frisco's Restaurant Group, Inc. | 6,125,000 | reported | 04 Jun 2019 | tx 30+640,000 |
| Avalo Therapeutics, Inc. | 4,415,000 | reported | 07 Feb 2023 | tx 244+92,990,308−12,537 |
| TENAX THERAPEUTICS, INC. | 1,987,995 | reported | 03 Sept 2020 | tx 22+464,384 |
| Valeritas Holdings Inc. | 1,060,000 | reported | 24 May 2019 | tx 19+550,000 |
| KIORA PHARMACEUTICALS INC | 785,000 | reported | 02 Aug 2021 | tx 42+16,274,472−260,963 |
| ADVANCED MAGNETICS INC | 324,000 | reported | 25 Feb 2020 | tx 5+336,000 |
| BIO-PATH HOLDINGS INC | 129,298 | reported | 18 Jan 2019 | tx 3−64,457 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2023 | PURCHASE | Avalo Therapeutics, Inc. | 334 | 3.95 USD | |
| 07 Feb 2023 | PURCHASE | Avalo Therapeutics, Inc. | 450,000 | — | |
| 07 Feb 2023 | PURCHASE | Avalo Therapeutics, Inc. | 450,000 | — | deriv |
| 10 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 26,000 | 0.70 USD | |
| 11 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 100,000 | 0.69 USD | |
| 14 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 100,000 | 0.65 USD | |
| 18 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 206,300 | 0.88 USD | |
| 20 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 12,000 | 0.85 USD | |
| 19 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 93,700 | 0.88 USD | |
| 15 Sept 2021 | PURCHASE | Avalo Therapeutics, Inc. | 95,455 | 2.26 USD | |
| 16 Sept 2021 | PURCHASE | Avalo Therapeutics, Inc. | 150,000 | 2.28 USD | |
| 17 Sept 2021 | PURCHASE | Avalo Therapeutics, Inc. | 5,454,545 | 2.20 USD | anomaly |
| 06 Aug 2021 | PURCHASE | Avalo Therapeutics, Inc. | 25,000 | 2.83 USD | |
| 05 Aug 2021 | PURCHASE | Avalo Therapeutics, Inc. | 25,000 | 2.77 USD | |
| 04 Aug 2021 | PURCHASE | Avalo Therapeutics, Inc. | 100,000 | 2.69 USD | |
| 02 Aug 2021 | SALE | KIORA PHARMACEUTICALS INC | 192,775 | 2.40 USD | |
| 30 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 68,188 | 2.69 USD | |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 5,330,277 | — | |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 0 | 0.00 USD | |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 0 | 0.00 USD | deriv |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 0 | 0.00 USD | deriv |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 0 | 0.00 USD | deriv |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 1,200,000 | — | deriv |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 1,000,000 | — | deriv |
| 15 Jun 2021 | OTHER | EnteroMedics Inc | 4,000,000 | — | deriv |